U.S. market Closed. Opens in 11 hours 28 minutes

GRTS | Gritstone bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue1.33M9.27M46.72M4.04M4.37M1.19MN/AN/A
Cost of Revenue7.59M15.69M14.40M88.64M82.90MN/AN/AN/A
Gross Profit-6.26M-6.42M32.32M-84.61M-78.53M1.19MN/AN/A
Operating Expenses148.37M129.70M121.93M110.05M102.31M66.77M41.76MN/A
Selling, General & Admin21.19M28.97M25.93M21.41M19.41M11.81M6.07M5.06M
Research & Development127.18M111.40M97.49M88.64M82.90M54.97M35.69M13.92M
Other Operating Expenses-32.00K-10.68M-1.50MN/AN/AN/AN/AN/A
Operating Income-154.63M-120.43M-75.21M-106.02M-97.94M-65.58M-41.76M-18.98M
Other Expenses / Income16.14M741.00K127.00K703.00K3.51M809.00K386.00K230.00K
Before Tax Income-138.49M-119.69M-75.08M-105.31M-94.43M-64.78M-41.38M-18.75M
Income Tax Expenses7.42M-6.56M-127.00K-703.00K-3.51M809.00KN/AN/A
Net Income-138.49M-113.13M-74.95M-104.61M-90.93M-64.78M-41.38M-18.75M
Interest Expenses4.04M1.24M37.00K12.00KN/AN/AN/AN/A
Basic Shares Outstanding115.53M90.92M78.89M37.79M33.55M8.92M13.70M20.09M
Diluted Shares Outstanding115.53M90.92M78.89M37.79M33.55M8.92M13.70M20.09M
EBITDA-147.04M-118.45M-68.86M-99.37M-93.19M-61.62M-39.41M-18.16M
EBITDA Margin-11,047.56%-1,277.94%-147.40%-2,461.56%-2,135.05%-5,191.49%0.00%0.00%
EBIT-127.03M-118.45M-75.05M-105.30M-94.43M-63.97M-41.38M-18.75M
EBIT Margin-9,544.02%-1,277.94%-160.64%-2,608.42%-2,163.41%-5,388.88%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙